Condition
Cancer
Estimated Enrollment: 42
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 05-002|12,158
Study First Received: September 16, 2005
Last Updated: January 15, 2016
Estimated Primary Completion Date: October 2013
Primary Outcome Measures:
Time-to-progression (TTP)|Objective Response Rate (ORR)|Disease Control Rate (DCR)|Overall Survival (OS)
Sponsors and Collaborators:
University of Pittsburgh|Eli Lilly and Company|Genentech, Inc.
Website Link: https://ClinicalTrials.gov/show/NCT00222729
